Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-13-002032
Filing Date
2013-04-16
Accepted
2013-04-16 16:17:35
Documents
8
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT hbmk_10k.htm 10-K 1518887
2 MAXIMUM AMOUNT MORTGAGE CONTRACT hbmk_ex1012.htm EX-10.12 106327
3 LOAN CONTRACT FOR WORKING CAPITAL hbmk_ex1013.htm EX-10.13 162981
4 LOAN CONTRACT FOR WORKING CAPITAL hbmk_ex1014.htm EX-10.14 169605
5 CERTIFICATION hbmk_ex311.htm EX-31.1 15666
6 CERTIFICATION hbmk_ex312.htm EX-31.2 16280
7 CERTIFICATION hbmk_ex321.htm EX-32.1 8634
8 img001.jpg GRAPHIC 26815
  Complete submission text file 0001354488-13-002032.txt   2036727
Mailing Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864
Business Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864 65-6747-7883
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53231 | Film No.: 13764154
SIC: 2834 Pharmaceutical Preparations